MONSEY, N.Y., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of scPharmaceuticals, Inc. (Nasdaq: SCPH) (“SCPH”) to MannKind Corporation (“MannKind”) for $5.35 per share in cash, plus one non-tradable contingent value right (“CVR”) per share offering milestone-based payments of up to $1.00 per share. As detailed below, the sales price is below the price targets for SCPH of multiple Wall Street analysts covering SCPH prior to the announcement (s ...

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of WK Kellogg Co. to Ferrero Group for $23.00 per share in cash, following concerns raised by investors regarding the sale price [1][2]. Group 1: Sale Details - Kellogg announced an agreement to be sold to Ferrero Group for $23.00 per share in cash on July 10, 2025 [2]. - At least one investor has publicly expressed disappointment with the sale price, claiming that shareholders are being unfairly treated [2]. Group 2: Investigation Purpose - The investigation aims to determine if the Kellogg Board of Directors acted in the best interests of shareholders when approving the sale [2]. - The inquiry will assess whether the agreed price is fair and if all material information regarding the transaction has been fully disclosed [2]. Group 3: Firm Background - Wohl & Fruchter LLP has over a decade of experience representing investors in litigation related to fraud and corporate misconduct, recovering hundreds of millions of dollars for investors [3].